Latest filing published 01 Apr 2026 for Wuhan YZY Biopharma Co., Ltd. - B.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
WEN Zhicheng: trading record in brief
All filings by WEN Zhicheng on record concern Wuhan YZY Biopharma Co., Ltd. - B, in the capacity of chief executive. In total, 2 filings cover trades dated 30 March 2026.
Market trades split into 1 purchase and 1 sale. The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The newest entry dates from 1 April 2026: an open-market purchase, in Wuhan YZY Biopharma Co., Ltd. - B. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to WEN Zhicheng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,059,039 sharesShareXHKGHKEX:DA20260331E00384Canonical exit: 28 Jun 2026 (T+90)
- 5,059,039 sharesShareXHKGHKEX:DA20260331E00383
2 of 2 declarations